Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glaukos (GKOS) Capital Expenditures (2016 - 2025)

Glaukos (GKOS) has disclosed Capital Expenditures for 12 consecutive years, with -$1.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Capital Expenditures fell 129.62% to -$1.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.9 million, a 53.65% decrease, with the full-year FY2025 number at $2.9 million, down 53.65% from a year prior.
  • Capital Expenditures was -$1.8 million for Q4 2025 at Glaukos, down from $1.6 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $33.8 million in Q3 2021 to a low of -$36.2 million in Q4 2021.
  • A 5-year average of $1.8 million and a median of $1.1 million in 2024 define the central range for Capital Expenditures.
  • Peak YoY movement for Capital Expenditures: plummeted 1787.41% in 2021, then surged 3062.71% in 2023.
  • Glaukos' Capital Expenditures stood at -$36.2 million in 2021, then surged by 101.49% to $539000.0 in 2022, then soared by 3062.71% to $17.0 million in 2023, then plummeted by 63.71% to $6.2 million in 2024, then crashed by 129.62% to -$1.8 million in 2025.
  • Per Business Quant, the three most recent readings for GKOS's Capital Expenditures are -$1.8 million (Q4 2025), $1.6 million (Q3 2025), and $1.2 million (Q2 2025).